PLOS Neglected Tropical Diseases Journal Information

About PLOS Neglected Tropical Diseases

PLOS Neglected Tropical Diseases (eISSN 1935-2735) is the first open-access journal devoted to the world's most neglected tropical diseases (NTDs), such as elephantiasis, river blindness, leprosy, hookworm, schistosomiasis, and African sleeping sickness. The journal publishes high-quality, peer-reviewed research on all scientific, medical, and public-health aspects of these forgotten diseases affecting the world's forgotten people.

PLOS Neglected Tropical Diseases is particularly keen to publish research from authors in countries where the NTDs are endemic. It aims to:

  • Provide a forum for the NTDs community of scientific investigators, health practitioners, control experts, and advocates to publish their findings in an open-access format
  • Promote and profile the efforts of scientists, health practitioners, and public-health experts from endemic countries, and build science and health capacity in those countries
  • Highlight the global public-health importance of the NTDs and advocate for the plight of the poor who suffer from these diseases in endemic countries

PLOS Neglected Tropical Diseases is published online by PLOS, a nonprofit organization. The journal's start-up phase is supported by a grant from the Bill and Melinda Gates Foundation.

PLOS Neglected Tropical Diseases is indexed in PubMed, PubMed Central, Scopus, Google Scholar, and the Web of Science.


PLOS Neglected Tropical Diseases is devoted to the pathology, epidemiology, treatment, control, and prevention of the NTDs, as well as public policy relevant to this group of diseases.

The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. They are poverty-promoting because of their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features.

To see which diseases are included in the journal, please read the detailed scope.


Original Research Papers

Research articles consider all aspects of the NTDs, including their pathogenesis, clinical features, pharmacology and treatment, diagnosis, epidemiology, vector biology, and vaccinology and prevention. Demographic, ecological and social determinants, public health, and policy aspects of these diseases (including cost-effectiveness analyses) are also a priority. PLOS Neglected Tropical Diseases is pleased to publish relevant in vitro and animal studies as well as human investigations. The journal is organized to provide additional support for authors from endemic countries, and such authors are particularly encouraged to submit their research to PLOS Neglected Tropical Diseases. Academic editors, supported by expert peer-reviewers, will select for publication those studies that drive their respective fields forward.

Please refer to our Author Guidelines for instructions on preparing research manuscripts.

The Magazine Section

The Editorial is written by the Editor-in-Chief or a member of the Editorial Board.

The Viewpoints section contains opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

The Debate section highlights controversial issues in the field of NTDs.

The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

The Reviews section is for authors to summarize the best available evidence on a topic relevant to the NTD community.

In an Expert Commentary, authors discuss the clinical, policy, public-health, or research implications of a freely available research article.

From Innovation to Application is a section in which authors discuss new technologies, including drugs, vaccines, and diagnostics.

The Photo Quiz presents a clinical image and brief case discussion followed by questions, learning points, and key references.

In the Symposium section, authors discuss a "real world" problem, from the clinic, laboratory, or community, and how best it can be tackled.

Historical Profiles & Perspectives look back in history to discuss a notable figure or a control program that worked or failed.

Interviews highlight the work of a person who has made a notable contribution to controlling NTDs.

Open Access

PLOS applies the Creative Commons Attribution License (CCAL) to all works we publish. Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in PLOS journals, so long as the original authors and source are cited. No permission is required from the authors or the publishers.

Publication Fees

To provide Open Access, PLOS uses a business model to offset expenses—including those of peer review management, journal production and online hosting and archiving—by charging a publication fee to the authors, institutions or funders for each article published.

Publication fees vary by journal and are payable for articles upon acceptance. PLOS has specific terms and publication charges for articles that are part of a Special Collection. To find out more visit our Special Collection Fees page.

PLOS believes that lack of funds should not be a barrier to Open Access publication. Since its inception, PLOS has provided individual fee support and institutional fee support programs. The current offering includes:

PLOS Global Participation Initiative (Low- and Middle-Income Country Assistance)

Authors' research which is funded primarily (50% or more of the work contained within the article) by an institution or organization from eligible low- and middle-income countries will receive partial (group 2 countries) or full (group 1 countries) fee funding paid by the PLOS Global Participation Initiative (GPI). Group 2 PLOS GPI country authors who need to request additional support should apply for PLOS Publication Fee Assistance instead of the PLOS GPI.

PLOS Publication Fee Assistance (PFA)

Publication Fee Assistance is intended for authors who demonstrate financial need. Information about an applicant's application status for fee assistance will not be disclosed to journal editors or reviewers. PLOS publication decisions will continue to be based solely on editorial criteria.

PLOS Institutional Fee Support Program

PLOS currently offers an institutional program to support Open Access scientific publishing. Participating institutions have arrangements with PLOS to administer payment for full publication fees for their institutions' authors. To be eligible, authors must be a corresponding author affiliated with the institution or agency in the Institutional Account Program (fully paid or restricted). (Special note to UK authors — certain institutions will restrict payment to cover for Wellcome Trust and RCUK research grant recipients only.) Authors who need to request additional support should apply for PLOS PFA.

Additional External Funds

Authors may also be eligible for direct funding from their institution or funder, which may be different from the PLOS Institutional program. See additional Open Access funds for examples. To confirm amounts and details of funding and eligibility, contact the organization as indicated.

Measures of Impact

At PLOS, we believe that articles in all journals should be assessed on their own merits rather than on the basis of the journal in which they were published.  PLOS journals have therefore initiated a program to provide a growing set of measures and indicators of impact at the article level that will include citation metrics, usage statistics, blogosphere coverage, social bookmarks and expert assessment. The long-term vision is to bring the views and activities of entire communities to bear, using the wealth of opportunities offered online, to provide new, meaningful and efficient mechanisms for research assessment. For more information on article-level metrics see the PLOS blog.

About PLOS

PLOS is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information about PLOS, visit